Inato Stock
Inato is a platform designed for clinical trials that can unlock research site potential.
Sign up today and learn more about Inato Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Inato Stock
Inato automates data structuring and analysis, cross-checks data sources, and provides insights on this data. It features a tool for collecting and analyzing data used in clinical trials, Inato’s AI-powered platform enables pharmaceutical companies to drastically reduce drug development costs. By accelerating clinical trials, Inato helps new therapies arrive to patients faster, and at lower prices
Funding History
| November 2017 | $1.3M |
|---|---|
| February 2020 | $14.0M |
Management
Co-Founder and CPO
William Pambrun
Chief Strategy Officer
Liz Beatty
Co-Founder and Chief Medical Officer
Jean-David Zeitoun
Co-Founder and Chief Scientific Officer
Philippe Ravaud
Co-Founder and CEO
Kourosh Davarpanah
Press
fastcompany - Apr, 8 2024
Why Inato is one of the most innovative biotech companies of 2024mobihealthnews - Dec, 20 2023
Predictions for digital health funding in 2024outsourcing-pharma - Dec, 20 2023
Women in Science: Inato's Liz Beatty and her aim to combat ...axios - Dec, 20 2023
Clinical trials infrastructure tech: State of playmobihealthnews - Mar, 30 2023
Inato raises $20M to expand clinical trial site matching platformEquityZen Recognized As:
